Serena Williams Weight Loss: GLP-1 Confession and How She Lost 31-34 Pounds

When a world-class athlete like Serena Williams shares a fitness milestone, the internet tends to pay attention—especially when the conversation shifts to weight loss and medication. The buzz started in August 2025 when Williams revealed she had shed 31 to 34 pounds with the help of a GLP-1 medication, though she kept the specific brand under wraps.

Weight lost: 31-34 pounds | Duration: 8-20 months | Method: GLP-1 medication | Age: 43 | Year started: 2024

The table below outlines the fundamental details of Serena Williams’ weight loss journey as reported across multiple outlets.

What stands out here is the deliberate ambiguity: Williams has been transparent about the outcome and the tool, but not the specific brand or her current weight. That gap has fueled curiosity and, at times, misinformation.

How did Serena Williams lose weight?

Serena Williams first opened up about her weight loss in an interview where she confirmed using a GLP-1 medication. She was quick to note that it was not an “easy” path, countering the assumption that medication alone did the heavy lifting.

According to Reuters, Williams said the medication route was not a shortcut, and she emphasized the work she put in alongside it. She did not specify the exact drug, but she did confirm that it was in the GLP-1 class, which includes popular options like Ozempic and Wegovy.

The implication: Serena’s admission reframes the GLP-1 conversation for athletes and postpartum women.

Did Serena Williams use Ozempic for weight loss?

The short answer is: we don’t know. Serena has not publicly named the specific GLP-1 medication she used. Reports from ABC7 indicate she mentioned using an undisclosed GLP-1, but she has declined to specify further, citing the need to see what works for others.

The catch: By staying vague, Serena avoids endorsement but fuels speculation.

What Did Venus Williams Say About Her Weight Loss?

Venus Williams found herself in the spotlight after fans speculated about her appearance. In response, she addressed the comments directly, confirming she was not using the same medication as her sister. Venus told fans to “stop body shaming” and clarified that she has not taken GLP-1 drugs.

Venus’s comments highlight the pressure that comes with public scrutiny. Her reaction was a reminder that while the sisters share a last name, their health journeys are entirely their own.

The pattern: The Williams sisters navigate public scrutiny differently, underscoring individual health choices.

What Does the Medical Community Say About GLP-1s?

Medical experts have weighed in on the broader trend of GLP-1 use, offering context beyond the celebrity headlines. According to analysis from Healthline, these medications are approved for weight management but come with potential side effects and are not suitable for everyone.

The implication: Medical supervision is crucial before starting any weight-loss medication.

How much does Serena weigh now?

Serena has not disclosed her current weight. She reported losing 31-34 pounds, but exact numbers are not public. Before her weight loss, her tennis playing weight was estimated around 175-200 lbs, but this has not been confirmed.

The pattern: The ambiguity around her current weight leaves room for speculation but also protects her privacy.

Why Won’t She Disclose the Specific Drug?

The question on everyone’s mind is why Serena won’t name the drug. While she hasn’t explained her reasoning, experts suggest that celebrity endorsements carry weight, and choosing not to name a brand might be a deliberate PR move.

It could also be a personal decision, as she may not want to appear as though she’s promoting a specific product. Either way, the silence has opened the door to speculation, but it hasn’t diminished the impact of her revelation.

What this means: The silence may be strategic to avoid brand endorsement.

Is GLP-1 the Right Choice for Everyone?

While Serena’s results are impressive, medical experts are quick to point out that GLP-1s are not for everyone. The medication requires a prescription and is typically intended for people with a BMI over 30 or those with weight-related health conditions. Side effects can include nausea, vomiting, and more serious risks like pancreatitis, making it critical to consult a healthcare provider.

The reporting from ABC News Australia has also highlighted that Williams had to “figure out” a different approach if she wanted to keep the weight off, emphasizing that the drug is a tool, not a cure-all.

The Bigger Picture of GLP-1 Use

Serena’s disclosure has reignited the debate about weight loss drugs in the public eye. It’s a conversation that touches on body image, celebrity culture, and the lengths people go to to feel good in their own skin. While the details of her journey remain private, the effect of her candidness is public—and it’s prompting many to have honest conversations with their doctors about what’s right for them.

Summary: The Path Forward

Serena Williams’ weight loss is a story about agency over a narrative that was already being written for her. She has taken control of her health on her own terms, setting a precedent for others who might be considering similar routes. This moment in the spotlight will likely fade, but the conversation about GLP-1s and the pressure on public figures to disclose their choices is just beginning. As these discussions continue, one thing is clear: the takeaway for the public is not the drug, but the importance of having a health plan that works for the individual, not for the cameras.

Frequently Asked Questions